[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![TrendFriend8 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1333249596320063490.png) Trend Friend [@TrendFriend8](/creator/twitter/TrendFriend8) on x XX followers
Created: 2025-07-17 13:15:18 UTC

$SRPT short interest just hit ~17.5% of float with only ~1.2 days to cover. Borrow rates still low, but setup is ripe. FDA just cleared Elevidys to stay on market. With high short fuel + fresh catalyst, Sarepta is officially on short squeeze watch. 🚨👀 

Follow 👉 @TrendFriend8


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945834696744616204/c:line.svg)

**Related Topics**
[rates](/topic/rates)
[$282m](/topic/$282m)
[$513m](/topic/$513m)
[savings](/topic/savings)
[$400m](/topic/$400m)
[chapter 11](/topic/chapter-11)
[$srpt](/topic/$srpt)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)

[Post Link](https://x.com/TrendFriend8/status/1945834696744616204)